Alirocumab can address unmet needs in pediatric familial hypercholesterolemia: GlobalData
Praluent (alirocumab) is a monoclonal antibody against proprotein convertase subtilisin kexin type 9 (PCSK9), an enzyme that…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.